KRAS-mutant NSCLC cells are more radioresistant than KRAS wild-type cells (96, 110) or EGFR-mutant cells (21), because mutant KRAS can upregulate RAD51 expression through oncogene MYC, thereby enhancing DNA damage repair and cell survival (111). This evidence concerns the gene KRAS and non-small cell lung carcinoma.